Answers are grounded in this paper and cite their sources.
Conference review reveals key translational advances across 19 unconventional animal models, highlighting the value of cross-species approaches for Alzheimer's disease research.
Alzheimer’s disease (AD) remains a major unmet medical challenge, highlighting the need for improved experimental models. The second Unconventional Animal Models of Alzheimer’s Disease and Aging (UAMAA 2026) conference brought together ~150 interdisciplinary researchers to discuss advances across 19 animal models of AD and aging. Six major themes emerged: naturally occurring AD-like pathology, neuroinflammation, population heterogeneity, development of genomic and molecular resources, companion dogs as translational models and the promise of laboratory-amenable species such as the Chilean degu and common marmoset. These discussions highlighted the growing value of cross-species approaches for advancing translational AD research.
No takes yet. Share an insight, caveat, or question.
Garduño et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: